{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:14:26Z","timestamp":1790727266413,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jad.2025.120783","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:47:22Z","timestamp":1764290842000},"page":"120783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"PB","title":["The association between depressive symptom severity and metabolic disturbances in major depressive and bipolar disorders: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"395","author":[{"given":"Sabrina","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan F.","family":"Guillen-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi K.Y.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McInyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120783_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067194","article-title":"Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial","volume":"376","author":"Abbar","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2025.120783_bb0010","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.120783_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2025.03.198","article-title":"Does BMI matter when treating depression with esketamine? A retrospective analysis of real-world data","volume":"381","author":"Ansari","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2024.11.019","article-title":"A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: target engagement and rationale for the development in mental disorders","volume":"370","author":"Au","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0025","article-title":"Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review","volume":"37","author":"Au","year":"2025","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jad.2025.120783_bb4000","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.psyneuen.2015.01.026","article-title":"Associations between HbA1c and depressive symptoms in young adults with early-onset type 1 diabetes","volume":"55","author":"B\u00e4chle","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2025.120783_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4103\/2230-8210.100670","article-title":"Association of depression and its relation with complications in newly diagnosed type 2 diabetes","volume":"16","author":"Bajaj","year":"2012","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"10.1016\/j.jad.2025.120783_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1192\/bjp.2019.167","article-title":"Suicidal risk factors in major affective disorders","volume":"215","author":"Baldessarini","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.jad.2025.120783_bb0045","article-title":"Ketamine for bipolar depression: biochemical, psychotherapeutic, and psychedelic approaches","volume":"13","author":"Bennett","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.120783_bb0050","article-title":"Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.120783_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolardisorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0060","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14022","article-title":"Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD Study): a randomized, quadruple-masked, placebo-controlled clinical trial","volume":"83","author":"Calkin","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2023.03.007","article-title":"Associations between individual depressive symptoms and immunometabolic characteristics in major depression","volume":"71","author":"Chae","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.120783_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jad.2013.04.008","article-title":"The change of insulin levels after six weeks antidepressant use in drug-na\u00efve major depressive patients","volume":"150","author":"Chang","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00406-023-01581-2","article-title":"Prevalence, risk factors and clinical correlates of glucose disturbances in a large sample of Han Chinese patients with first-episode drug-na\u00efve major depressive disorder","volume":"274","author":"Chen","year":"2024","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.120783_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.4525","article-title":"Metabolic profile and long-term risk of depression, anxiety, and stress-related disorders","volume":"7","author":"Chourpiliadis","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2025.120783_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028912","article-title":"Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study","volume":"7","author":"Cizza","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2025.120783_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpsychires.2023.05.041","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: a systematic review","volume":"164","author":"Cooper","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.120783_bb0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jad.2020.12.121","article-title":"Body mass index and blood pressure in bipolar patients: target cardiometabolic markers for clinical practice","volume":"282","author":"Cuellar-Barboza","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.861311","article-title":"NMDA receptor antagonists increase the release of GLP-1 from gut endocrine cells","volume":"13","author":"Cyranka","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2025.120783_bb0105","series-title":"Immuno-psychiatry: Facts and Prospects","first-page":"259","article-title":"Inflammation and depression: is immunometabolism the missing link?","author":"Dantzer","year":"2021"},{"key":"10.1016\/j.jad.2025.120783_bb0110","first-page":"1","article-title":"Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care data","author":"Fanelli","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104758","article-title":"Insulin resistance in depression: a large meta-analysis of metabolic parameters and variation","volume":"139","author":"Fernandes","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.120783_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/dc06-1614","article-title":"Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics","volume":"30","author":"Fisher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jad.2025.120783_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/JCP.0000000000001209","article-title":"Body mass index as a moderator of treatment response to ketamine for major depressive disorder","volume":"40","author":"Freeman","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120783_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2024.12.090","article-title":"Metabolic factors modulate effort-based decision-making in major depressive disorder","volume":"373","author":"Gill","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpsychires.2022.12.024","article-title":"Evaluating anhedonia as a risk factor in suicidality: a meta-analysis","volume":"158","author":"Gillissie","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.120783_bb0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jad.2021.03.032","article-title":"Is obesity a determinant of success with pharmacological treatment for depression? A systematic review, meta-analysis and meta-regression","volume":"287","author":"Grigolon","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/bdi.12195","article-title":"Differences in incidence of suicide attempts between bipolar I and II disorders and major depressive disorder","volume":"16","author":"Holma","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22048-9","article-title":"Identifying high-risk population of depression: association between metabolic syndrome and depression using a health checkup and claims database","volume":"12","author":"Imaizumi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.120783_bb0155","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1092852922001043","article-title":"The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia","volume":"28","author":"Jawad","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.120783_bb0160","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/bph.15682","article-title":"Glucagon-like peptide-1 (GLP-1) signalling in the brain: from neural circuits and metabolism to therapeutics","volume":"179","author":"Kabahizi","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jad.2025.120783_bb0165","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s43440-024-00621-5","article-title":"Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder","volume":"76","author":"Krupa","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jad.2025.120783_bb0170","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jad.2024.08.057","article-title":"Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: a systematic review and meta-analysis","volume":"365","author":"Le","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jad.2024.09.118","article-title":"Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: a systematic review and meta-analysis","volume":"368","author":"Le","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psychres.2018.06.061","article-title":"Factors related to metabolic parameters in medicated patients with major depressive disorder\u2013\u2013a naturalistic study","volume":"268","author":"Lee","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120783_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12991-024-00527-9","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review","volume":"23","author":"Lee","year":"2024","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jad.2021.12.110","article-title":"Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: a systematic review and meta-analysis","volume":"300","author":"Liu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.genhosppsych.2014.05.018","article-title":"The metabolic syndrome and related characteristics in major depression: inpatients and outpatients compared: metabolic differences across treatment settings","volume":"36","author":"Luppino","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0200","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12888-019-2131-6","article-title":"The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0205","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1017\/S0033291724000345","article-title":"Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis","volume":"54","author":"Maksyutynska","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2025.120783_bb0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/bdi.12826","article-title":"Parsing metabolic heterogeneity in mood disorders: a hypothesis-driven cluster analysis of glucose and insulin abnormalities","volume":"22","author":"Mansur","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2190\/PM.45.3.a","article-title":"Metabolic syndrome: differences between psychiatric and internal medicine patients","volume":"45","author":"Margari","year":"2013","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.jad.2025.120783_bb0220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1176\/appi.ajp.2021.21080814","article-title":"Surrogate markers of insulin resistance in predicting major depressive disorder: metabolism metastasizes to the brain","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10401230701653377","article-title":"Should depressive syndromes be reclassified as \u201cmetabolic syndrome type II\u201d?","volume":"19","author":"McIntyre","year":"2007","journal-title":"Ann. Clin. Psychiatry Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.jad.2025.120783_bb0230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0235","first-page":"394","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry Off. J. World Psychiatr. Assoc. WPA"},{"key":"10.1016\/j.jad.2025.120783_bb0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1176\/appi.ajp.20230922","article-title":"Psychotropic drug\u2013related weight gain and its treatment","volume":"181","author":"McIntyre","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0245","volume":"30","author":"McIntyre","year":"2025","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.120783_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2023.04.068","article-title":"Insulin resistance in bipolar disorder: a systematic review of illness course and clinical correlates","volume":"334","author":"Miola","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpsychires.2017.03.025","article-title":"Metabolic syndrome in subjects with bipolar disorder and major depressive disorder in a current depressive episode: population-based study: metabolic syndrome in current depressive episode","volume":"92","author":"Moreira","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.120783_bb0265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/hsz-2022-0236","article-title":"NMDA receptors - regulatory function and pathophysiological significance for pancreatic beta cells","volume":"404","author":"Noguera Hurtado","year":"2023","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jad.2025.120783_bb0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.31887\/DCNS.2008.10.3\/dnutt","article-title":"Sleep disorders as core symptoms of depression","volume":"10","author":"Nutt","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.120783_bb0275","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/acps.12470","article-title":"Metabolic syndrome in first-time hospitalized patients with depression: a 1-year follow-up study","volume":"133","author":"Nyboe","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.120783_bb0280","article-title":"Bipolar disorders: an update on critical aspects","volume":"48","author":"Oliva","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jad.2025.120783_bb0285","series-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","author":"Page","year":"2021"},{"key":"10.1016\/j.jad.2025.120783_bb0290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.17219\/acem\/63023","article-title":"The relationship between major depressive disorder and glucose parameters: a cross-sectional study in a Chinese population","volume":"26","author":"Peng","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.jad.2025.120783_bb0295","article-title":"Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: undirected and Bayesian network analyses","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jad.2025.120783_bb0300","article-title":"Immuno-metabolic depression: from concept to implementation","volume":"48","author":"Penninx","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.jad.2025.120783_bb0305","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41586-024-07419-8","article-title":"GLP-1-directed NMDA receptor antagonism for obesity treatment","volume":"629","author":"Petersen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jad.2025.120783_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105298","article-title":"Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses","volume":"152","author":"Possidente","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.120783_bb0315","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2020.12.074","article-title":"Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder","volume":"282","author":"Rashidian","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0320","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/02698811221132473","article-title":"Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder","volume":"37","author":"Rashidian","year":"2023","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.jad.2025.120783_bb0325","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.120783_bb0330","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpsychores.2015.02.010","article-title":"Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls","volume":"78","author":"Silarova","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2025.120783_bb0335","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41380-018-0093-6","article-title":"Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states","volume":"25","author":"Simmons","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2025.120783_bb0340","first-page":"BC17","article-title":"Metabolic syndrome: differences between psychiatric and internal medicine patients","volume":"12","author":"Singhal","year":"2018","journal-title":"JCDR"},{"issue":"1","key":"10.1016\/j.jad.2025.120783_bb0345","first-page":"34","article-title":"Psycho-social and clinical variables associated with depression in patients with type 2 diabetes","volume":"23","author":"Stankovi\u0107","year":"2011","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.jad.2025.120783_bb0350","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00406-018-0865-7","article-title":"Glucose homeostasis in major depression and schizophrenia: a comparison among drug-na\u00efve first-episode patients","volume":"269","author":"Steiner","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.120783_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.38313.513310.F71","article-title":"Insulin resistance and depression: cross sectional study","volume":"330","author":"Timonen","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2025.120783_bb0360","doi-asserted-by":"crossref","first-page":"492","DOI":"10.34172\/hpp.2021.62","article-title":"The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: a case-control study","volume":"11","author":"Vaghef-Mehrabani","year":"2021","journal-title":"Health Promot. Perspect."},{"key":"10.1016\/j.jad.2025.120783_bb0365","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4088\/JCP.15m10399","article-title":"Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults","volume":"78","author":"Virtanen","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0370","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/npp.2014.9","article-title":"Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users","volume":"39","author":"Vogelzangs","year":"2014","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.120783_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2000-7742","article-title":"Major depression and impaired glucose tolerance","volume":"108","author":"Weber","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jad.2025.120783_bb0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/2150131915627423","article-title":"Disease control among patients with diabetes and severe depressive symptoms","volume":"7","author":"Werremeyer","year":"2016","journal-title":"J. Prim. Care Community Health"},{"key":"10.1016\/j.jad.2025.120783_bb0385","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jad.2024.04.086","article-title":"Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: a systematic review and meta-analysis","volume":"356","author":"Wong","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0390","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12991-025-00574-w","article-title":"Suicide risk in persons with polycystic ovarian syndrome: a systematic review","volume":"24","author":"Wong","year":"2025","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0395","first-page":"241","article-title":"Functional connectivity between glutamate receptor antagonism and insulin pathways: implications for modeling mechanism of action of ketamine\/esketamine and dextromethorphan in depression treatment","volume":"10","author":"Wong","year":"2025","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.jad.2025.120783_bb0400","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.jad.2025.120783_bb0405","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jad.2020.11.059","article-title":"The association of body mass index (BMI) with treatment outcomes in patients with major depressive disorder","volume":"281","author":"Xiao","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120783_bb0410","first-page":"1","article-title":"The sigma-1 receptor: a mechanistically-informed therapeutic target for antidepressants","author":"Xiao","year":"2025","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jad.2025.120783_bb0415","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4082\/kjfm.2013.34.4.228","article-title":"Antidepressant use and diabetes mellitus risk: a Meta-analysis","volume":"34","author":"Yoon","year":"2013","journal-title":"Korean J. Fam. Med."},{"key":"10.1016\/j.jad.2025.120783_bb0420","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12888-020-02668-z","article-title":"Metabolic syndrome associated with the onset of depressive symptoms among women but not men in rural Northeast China","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.120783_bb0425","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12888-017-1539-0","article-title":"The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725022256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725022256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:10:53Z","timestamp":1783026653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725022256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":86,"alternative-id":["S0165032725022256"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120783","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between depressive symptom severity and metabolic disturbances in major depressive and bipolar disorders: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120783"}}